APO Research
Talk to an analyst

APO RESEARCH · REPORT

Taurine and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Taurine and Derivatives Market Analysis and Forecast 2026-2032

30 December 2025206 pages

Choose your research edition.

Industry ResearchTaurine and Derivatives Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Taurine and Derivatives Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Taurine and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Taurine and Derivatives Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Taurine and Derivatives Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Taurine and Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Taurine and Derivatives's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Taisho Pharmaceutical as the global sales leader, a title it has maintained for several consecutive years. Notably, Taisho Pharmaceutical's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Taurine and Derivatives market include Taisho Pharmaceutical, Yuanyang Pharmaceutical, Jiangyin Huachang, Yongan Pharmaceutical, Zhejiang NHU Co., Ltd and Grand Pharma, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Taurine and Derivatives production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Taurine and Derivatives by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Taurine and Derivatives, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Taurine and Derivatives, also provides the consumption of main regions and countries. Of the upcoming market potential for Taurine and Derivatives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Taurine and Derivatives sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Taurine and Derivatives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Taurine and Derivatives sales, projected growth trends, production technology, application and end-user industry.

Taurine and Derivatives Segment by Company

Taisho Pharmaceutical

Yuanyang Pharmaceutical

Jiangyin Huachang

Yongan Pharmaceutical

Zhejiang NHU Co., Ltd

Grand Pharma

Taurine and Derivatives Segment by Type

Taurine

Taurine Derivatives

Taurine and Derivatives Segment by Application

Beverages

Pet Food

Health Products

Others

Taurine and Derivatives Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Taurine and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Taurine and Derivatives production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Taurine and Derivatives in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Taurine and Derivatives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Taurine and Derivatives sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Taurine and Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Taurine Major Manufacturers Table 3. Taurine Derivatives Major Manufacturers Table 4. Global Taurine and Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Beverages Major Manufacturers Table 6. Pet Food Major Manufacturers Table 7. Health Products Major Manufacturers Table 8. Others Major Manufacturers Table 9. Taurine and Derivatives Industry Trends Table 10. Taurine and Derivatives Industry Drivers Table 11. Taurine and Derivatives Industry Opportunities and Challenges Table 12. Taurine and Derivatives Industry Restraints Table 13. Global Taurine and Derivatives Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 14. Global Taurine and Derivatives Production by Region (2021-2026) & (Tons) Table 15. Global Taurine and Derivatives Production by Region (2027-2032) & (Tons) Table 16. Global Taurine and Derivatives Production Market Share by Region (2021-2026) Table 17. Global Taurine and Derivatives Production Market Share by Region (2027-2032) Table 18. Global Taurine and Derivatives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Taurine and Derivatives Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Taurine and Derivatives Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Taurine and Derivatives Revenue Market Share by Region (2021-2026) Table 22. Global Taurine and Derivatives Revenue Market Share by Region (2027-2032) Table 23. Global Taurine and Derivatives Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 24. Global Taurine and Derivatives Sales by Region (2021-2026) & (Tons) Table 25. Global Taurine and Derivatives Sales by Region (2027-2032) & (Tons) Table 26. Global Taurine and Derivatives Sales Market Share by Region (2021-2026) Table 27. Global Taurine and Derivatives Sales Market Share by Region (2027-2032) Table 28. Global Taurine and Derivatives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Taurine and Derivatives Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Taurine and Derivatives Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Taurine and Derivatives Sales Market Share by Manufacturers (2021-2026) Table 32. Global Taurine and Derivatives Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 33. Global Taurine and Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Taurine and Derivatives Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Taurine and Derivatives Manufacturers, Product Type & Application Table 36. Global Taurine and Derivatives Manufacturers Commercialization Time Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Taurine and Derivatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 39. Global Taurine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Taurine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Taurine and Derivatives Revenue Market Share by Type (2021-2026) Table 42. Global Taurine and Derivatives Revenue Market Share by Type (2027-2032) Table 43. Global Taurine and Derivatives Sales by Type (2021-2026) & (Tons) Table 44. Global Taurine and Derivatives Sales by Type (2027-2032) & (Tons) Table 45. Global Taurine and Derivatives Sales Market Share by Type (2021-2026) Table 46. Global Taurine and Derivatives Sales Market Share by Type (2027-2032) Table 47. Global Taurine and Derivatives Price by Type (2021-2026) & (US$/Ton) Table 48. Global Taurine and Derivatives Price by Type (2027-2032) & (US$/Ton) Table 49. Global Taurine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Taurine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Taurine and Derivatives Revenue Market Share by Application (2021-2026) Table 52. Global Taurine and Derivatives Revenue Market Share by Application (2027-2032) Table 53. Global Taurine and Derivatives Sales by Application (2021-2026) & (Tons) Table 54. Global Taurine and Derivatives Sales by Application (2027-2032) & (Tons) Table 55. Global Taurine and Derivatives Sales Market Share by Application (2021-2026) Table 56. Global Taurine and Derivatives Sales Market Share by Application (2027-2032) Table 57. Global Taurine and Derivatives Price by Application (2021-2026) & (US$/Ton) Table 58. Global Taurine and Derivatives Price by Application (2027-2032) & (US$/Ton) Table 59. Taisho Pharmaceutical Company Information Table 60. Taisho Pharmaceutical Business Overview Table 61. Taisho Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 62. Taisho Pharmaceutical Taurine and Derivatives Product Portfolio Table 63. Taisho Pharmaceutical Recent Development Table 64. Yuanyang Pharmaceutical Company Information Table 65. Yuanyang Pharmaceutical Business Overview Table 66. Yuanyang Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolio Table 68. Yuanyang Pharmaceutical Recent Development Table 69. Jiangyin Huachang Company Information Table 70. Jiangyin Huachang Business Overview Table 71. Jiangyin Huachang Taurine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Jiangyin Huachang Taurine and Derivatives Product Portfolio Table 73. Jiangyin Huachang Recent Development Table 74. Yongan Pharmaceutical Company Information Table 75. Yongan Pharmaceutical Business Overview Table 76. Yongan Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Yongan Pharmaceutical Taurine and Derivatives Product Portfolio Table 78. Yongan Pharmaceutical Recent Development Table 79. Zhejiang NHU Co., Ltd Company Information Table 80. Zhejiang NHU Co., Ltd Business Overview Table 81. Zhejiang NHU Co., Ltd Taurine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolio Table 83. Zhejiang NHU Co., Ltd Recent Development Table 84. Grand Pharma Company Information Table 85. Grand Pharma Business Overview Table 86. Grand Pharma Taurine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Grand Pharma Taurine and Derivatives Product Portfolio Table 88. Grand Pharma Recent Development Table 89. North America Taurine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Taurine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Taurine and Derivatives Sales by Type (2021-2026) & (Tons) Table 92. North America Taurine and Derivatives Sales by Type (2027-2032) & (Tons) Table 93. North America Taurine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 94. North America Taurine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 95. North America Taurine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 96. North America Taurine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 97. North America Taurine and Derivatives Sales by Application (2021-2026) & (Tons) Table 98. North America Taurine and Derivatives Sales by Application (2027-2032) & (Tons) Table 99. North America Taurine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 100. North America Taurine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 101. North America Taurine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Taurine and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. North America Taurine and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. North America Taurine and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 105. North America Taurine and Derivatives Sales by Country (2021-2026) & (Tons) Table 106. North America Taurine and Derivatives Sales by Country (2027-2032) & (Tons) Table 107. North America Taurine and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 108. North America Taurine and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 109. United States Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 110. Canada Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 111. Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 112. Europe Taurine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Taurine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Taurine and Derivatives Sales by Type (2021-2026) & (Tons) Table 115. Europe Taurine and Derivatives Sales by Type (2027-2032) & (Tons) Table 116. Europe Taurine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 117. Europe Taurine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 118. Europe Taurine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Taurine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Taurine and Derivatives Sales by Application (2021-2026) & (Tons) Table 121. Europe Taurine and Derivatives Sales by Application (2027-2032) & (Tons) Table 122. Europe Taurine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 123. Europe Taurine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 124. Europe Taurine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Taurine and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. Europe Taurine and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. Europe Taurine and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 128. Europe Taurine and Derivatives Sales by Country (2021-2026) & (Tons) Table 129. Europe Taurine and Derivatives Sales by Country (2027-2032) & (Tons) Table 130. Europe Taurine and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 131. Europe Taurine and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 132. Germany Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 133. France Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 134. U.K. Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 135. Italy Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 137. China Taurine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 138. China Taurine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 139. China Taurine and Derivatives Sales by Type (2021-2026) & (Tons) Table 140. China Taurine and Derivatives Sales by Type (2027-2032) & (Tons) Table 141. China Taurine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 142. China Taurine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 143. China Taurine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 144. China Taurine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 145. China Taurine and Derivatives Sales by Application (2021-2026) & (Tons) Table 146. China Taurine and Derivatives Sales by Application (2027-2032) & (Tons) Table 147. China Taurine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 148. China Taurine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 149. Asia Taurine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Taurine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Taurine and Derivatives Sales by Type (2021-2026) & (Tons) Table 152. Asia Taurine and Derivatives Sales by Type (2027-2032) & (Tons) Table 153. Asia Taurine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 154. Asia Taurine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 155. Asia Taurine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Taurine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Taurine and Derivatives Sales by Application (2021-2026) & (Tons) Table 158. Asia Taurine and Derivatives Sales by Application (2027-2032) & (Tons) Table 159. Asia Taurine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 160. Asia Taurine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 161. Asia Taurine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Taurine and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Asia Taurine and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Asia Taurine and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 165. Asia Taurine and Derivatives Sales by Country (2021-2026) & (Tons) Table 166. Asia Taurine and Derivatives Sales by Country (2027-2032) & (Tons) Table 167. Asia Taurine and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 168. Asia Taurine and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 169. Japan Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 170. South Korea Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 171. India Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 172. Australia Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 173. China Taiwan Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 174. Southeast Asia Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 175. SAMEA Taurine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 176. SAMEA Taurine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 177. SAMEA Taurine and Derivatives Sales by Type (2021-2026) & (Tons) Table 178. SAMEA Taurine and Derivatives Sales by Type (2027-2032) & (Tons) Table 179. SAMEA Taurine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 180. SAMEA Taurine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 181. SAMEA Taurine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 182. SAMEA Taurine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 183. SAMEA Taurine and Derivatives Sales by Application (2021-2026) & (Tons) Table 184. SAMEA Taurine and Derivatives Sales by Application (2027-2032) & (Tons) Table 185. SAMEA Taurine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 186. SAMEA Taurine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 187. SAMEA Taurine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Taurine and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. SAMEA Taurine and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. SAMEA Taurine and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 191. SAMEA Taurine and Derivatives Sales by Country (2021-2026) & (Tons) Table 192. SAMEA Taurine and Derivatives Sales by Country (2027-2032) & (Tons) Table 193. SAMEA Taurine and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 194. SAMEA Taurine and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 195. Brazil Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 196. Argentina Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 197. Chile Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 198. Colombia Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 199. Peru Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 200. Saudi Arabia Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 201. Israel Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 202. UAE Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 203. Turkey Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 204. Iran Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 205. Egypt Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Taurine and Derivatives Distributors List Table 209. Taurine and Derivatives Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Taurine and Derivatives Product Image Figure 2. Global Taurine and Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Taurine and Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure . Taurine Image Figure 1. Taurine Derivatives Image Figure 2. Global Taurine and Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Taurine and Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure 4. Beverages Image Figure 5. Pet Food Image Figure 6. Health Products Image Figure 7. Others Image Figure 8. Global Taurine and Derivatives Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 9. Global Taurine and Derivatives Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 10. Global Taurine and Derivatives Production Market Share by Region: 2025 Versus 2032 Figure 11. Global Taurine and Derivatives Production Market Share by Region (2021-2032) Figure 12. North America Taurine and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 13. Europe Taurine and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 14. China Taurine and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 15. Japan Taurine and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 16. Global Taurine and Derivatives Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Taurine and Derivatives Revenue (2021-2032) & (US$ Million) Figure 18. Global Taurine and Derivatives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Taurine and Derivatives Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Taurine and Derivatives Revenue Market Share by Region (2021-2032) Figure 21. Global Taurine and Derivatives Sales (2021-2032) & (Tons) Figure 22. Global Taurine and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 23. Global Taurine and Derivatives Sales Market Share by Region (2021-2032) Figure 24. North America Taurine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 25. Europe Taurine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 26. China Taurine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 27. Asia (Excluding China) Taurine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 28. South America, Middle East and Africa Taurine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 29. Global Taurine and Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Taurine and Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Taurine and Derivatives Revenue Market Share by Type (2021-2032) Figure 33. Global Taurine and Derivatives Sales Market Share by Type (2021-2032) Figure 34. Global Taurine and Derivatives Revenue Market Share by Application (2021-2032) Figure 35. Global Taurine and Derivatives Sales Market Share by Application (2021-2032) Figure 36. North America Taurine and Derivatives Revenue Share by Type (2021-2032) Figure 37. North America Taurine and Derivatives Sales Share by Type (2021-2032) Figure 38. North America Taurine and Derivatives Revenue Share by Application (2021-2032) Figure 39. North America Taurine and Derivatives Sales Share by Application (2021-2032) Figure 40. North America Taurine and Derivatives Revenue Share by Country (2021-2032) Figure 41. North America Taurine and Derivatives Sales Share by Country (2021-2032) Figure 42. Europe Taurine and Derivatives Revenue Share by Type (2021-2032) Figure 43. Europe Taurine and Derivatives Sales Share by Type (2021-2032) Figure 44. Europe Taurine and Derivatives Revenue Share by Application (2021-2032) Figure 45. Europe Taurine and Derivatives Sales Share by Application (2021-2032) Figure 46. Europe Taurine and Derivatives Revenue Share by Country (2021-2032) Figure 47. Europe Taurine and Derivatives Sales Share by Country (2021-2032) Figure 48. China Taurine and Derivatives Revenue Share by Type (2021-2032) Figure 49. China Taurine and Derivatives Sales Share by Type (2021-2032) Figure 50. China Taurine and Derivatives Revenue Share by Application (2021-2032) Figure 51. China Taurine and Derivatives Sales Share by Application (2021-2032) Figure 52. Asia Taurine and Derivatives Revenue Share by Type (2021-2032) Figure 53. Asia Taurine and Derivatives Sales Share by Type (2021-2032) Figure 54. Asia Taurine and Derivatives Revenue Share by Application (2021-2032) Figure 55. Asia Taurine and Derivatives Sales Share by Application (2021-2032) Figure 56. Asia Taurine and Derivatives Revenue Share by Country (2021-2032) Figure 57. Asia Taurine and Derivatives Sales Share by Country (2021-2032) Figure 58. SAMEA Taurine and Derivatives Revenue Share by Type (2021-2032) Figure 59. SAMEA Taurine and Derivatives Sales Share by Type (2021-2032) Figure 60. SAMEA Taurine and Derivatives Revenue Share by Application (2021-2032) Figure 61. SAMEA Taurine and Derivatives Sales Share by Application (2021-2032) Figure 62. SAMEA Taurine and Derivatives Revenue Share by Country (2021-2032) Figure 63. SAMEA Taurine and Derivatives Sales Share by Country (2021-2032) Figure 64. Taurine and Derivatives Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Taurine and Derivatives Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Taurine
  • Taurine Derivatives
Applications
  • Beverages
  • Pet Food
  • Health Products
  • Others
Companies covered
  • Taisho Pharmaceutical
  • Yuanyang Pharmaceutical
  • Jiangyin Huachang
  • Yongan Pharmaceutical
  • Zhejiang NHU Co., Ltd
  • Grand Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Taurine and Derivatives Market by Type
  3. 1.2.1 Global Taurine and Derivatives Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Taurine
  5. 1.2.3 Taurine Derivatives
  6. 1.3 Taurine and Derivatives Market by Application
  7. 1.3.1 Global Taurine and Derivatives Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Beverages
  9. 1.3.3 Pet Food
  10. 1.3.4 Health Products
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Taurine and Derivatives Market Dynamics
  1. 2.1 Taurine and Derivatives Industry Trends
  2. 2.2 Taurine and Derivatives Industry Drivers
  3. 2.3 Taurine and Derivatives Industry Opportunities and Challenges
  4. 2.4 Taurine and Derivatives Industry Restraints
3 Global Taurine and Derivatives Production Overview
  1. 3.1 Global Taurine and Derivatives Production Capacity (2021-2032)
  2. 3.2 Global Taurine and Derivatives Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Taurine and Derivatives Production by Region
  4. 3.3.1 Global Taurine and Derivatives Production by Region (2021-2026)
  5. 3.3.2 Global Taurine and Derivatives Production by Region (2027-2032)
  6. 3.3.3 Global Taurine and Derivatives Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Taurine and Derivatives Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Taurine and Derivatives Revenue by Region
  3. 4.2.1 Global Taurine and Derivatives Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Taurine and Derivatives Revenue by Region (2021-2026)
  5. 4.2.3 Global Taurine and Derivatives Revenue by Region (2027-2032)
  6. 4.2.4 Global Taurine and Derivatives Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Taurine and Derivatives Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Taurine and Derivatives Sales by Region
  9. 4.4.1 Global Taurine and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Taurine and Derivatives Sales by Region (2021-2026)
  11. 4.4.3 Global Taurine and Derivatives Sales by Region (2027-2032)
  12. 4.4.4 Global Taurine and Derivatives Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Taurine and Derivatives Revenue by Manufacturers
  2. 5.1.1 Global Taurine and Derivatives Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Taurine and Derivatives Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Taurine and Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Taurine and Derivatives Sales by Manufacturers
  6. 5.2.1 Global Taurine and Derivatives Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Taurine and Derivatives Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Taurine and Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Taurine and Derivatives Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Taurine and Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Taurine and Derivatives Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Taurine and Derivatives Manufacturers, Product Type & Application
  13. 5.7 Global Taurine and Derivatives Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Taurine and Derivatives Market CR5 and HHI
  16. 5.8.2 2025 Taurine and Derivatives Tier 1, Tier 2, and Tier 3
6 Taurine and Derivatives Market by Type
  1. 6.1 Global Taurine and Derivatives Revenue by Type
  2. 6.1.1 Global Taurine and Derivatives Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Taurine and Derivatives Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Taurine and Derivatives Sales by Type
  5. 6.2.1 Global Taurine and Derivatives Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Taurine and Derivatives Sales Market Share by Type (2021-2032)
  7. 6.3 Global Taurine and Derivatives Price by Type
7 Taurine and Derivatives Market by Application
  1. 7.1 Global Taurine and Derivatives Revenue by Application
  2. 7.1.1 Global Taurine and Derivatives Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Taurine and Derivatives Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Taurine and Derivatives Sales by Application
  5. 7.2.1 Global Taurine and Derivatives Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Taurine and Derivatives Sales Market Share by Application (2021-2032)
  7. 7.3 Global Taurine and Derivatives Price by Application
8 Company Profiles
  1. 8.1 Taisho Pharmaceutical
  2. 8.1.1 Taisho Pharmaceutical Company Information
  3. 8.1.2 Taisho Pharmaceutical Business Overview
  4. 8.1.3 Taisho Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Taisho Pharmaceutical Taurine and Derivatives Product Portfolio
  6. 8.1.5 Taisho Pharmaceutical Recent Developments
  7. 8.2 Yuanyang Pharmaceutical
  8. 8.2.1 Yuanyang Pharmaceutical Company Information
  9. 8.2.2 Yuanyang Pharmaceutical Business Overview
  10. 8.2.3 Yuanyang Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolio
  12. 8.2.5 Yuanyang Pharmaceutical Recent Developments
  13. 8.3 Jiangyin Huachang
  14. 8.3.1 Jiangyin Huachang Company Information
  15. 8.3.2 Jiangyin Huachang Business Overview
  16. 8.3.3 Jiangyin Huachang Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Jiangyin Huachang Taurine and Derivatives Product Portfolio
  18. 8.3.5 Jiangyin Huachang Recent Developments
  19. 8.4 Yongan Pharmaceutical
  20. 8.4.1 Yongan Pharmaceutical Company Information
  21. 8.4.2 Yongan Pharmaceutical Business Overview
  22. 8.4.3 Yongan Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Yongan Pharmaceutical Taurine and Derivatives Product Portfolio
  24. 8.4.5 Yongan Pharmaceutical Recent Developments
  25. 8.5 Zhejiang NHU Co., Ltd
  26. 8.5.1 Zhejiang NHU Co., Ltd Company Information
  27. 8.5.2 Zhejiang NHU Co., Ltd Business Overview
  28. 8.5.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolio
  30. 8.5.5 Zhejiang NHU Co., Ltd Recent Developments
  31. 8.6 Grand Pharma
  32. 8.6.1 Grand Pharma Company Information
  33. 8.6.2 Grand Pharma Business Overview
  34. 8.6.3 Grand Pharma Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Grand Pharma Taurine and Derivatives Product Portfolio
  36. 8.6.5 Grand Pharma Recent Developments
9 North America
  1. 9.1 North America Taurine and Derivatives Market Size by Type
  2. 9.1.1 North America Taurine and Derivatives Revenue by Type (2021-2032)
  3. 9.1.2 North America Taurine and Derivatives Sales by Type (2021-2032)
  4. 9.1.3 North America Taurine and Derivatives Price by Type (2021-2032)
  5. 9.2 North America Taurine and Derivatives Market Size by Application
  6. 9.2.1 North America Taurine and Derivatives Revenue by Application (2021-2032)
  7. 9.2.2 North America Taurine and Derivatives Sales by Application (2021-2032)
  8. 9.2.3 North America Taurine and Derivatives Price by Application (2021-2032)
  9. 9.3 North America Taurine and Derivatives Market Size by Country
  10. 9.3.1 North America Taurine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Taurine and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Taurine and Derivatives Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
10 Europe
  1. 10.1 Europe Taurine and Derivatives Market Size by Type
  2. 10.1.1 Europe Taurine and Derivatives Revenue by Type (2021-2032)
  3. 10.1.2 Europe Taurine and Derivatives Sales by Type (2021-2032)
  4. 10.1.3 Europe Taurine and Derivatives Price by Type (2021-2032)
  5. 10.2 Europe Taurine and Derivatives Market Size by Application
  6. 10.2.1 Europe Taurine and Derivatives Revenue by Application (2021-2032)
  7. 10.2.2 Europe Taurine and Derivatives Sales by Application (2021-2032)
  8. 10.2.3 Europe Taurine and Derivatives Price by Application (2021-2032)
  9. 10.3 Europe Taurine and Derivatives Market Size by Country
  10. 10.3.1 Europe Taurine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Taurine and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Taurine and Derivatives Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Netherlands
11 China
  1. 11.1 China Taurine and Derivatives Market Size by Type
  2. 11.1.1 China Taurine and Derivatives Revenue by Type (2021-2032)
  3. 11.1.2 China Taurine and Derivatives Sales by Type (2021-2032)
  4. 11.1.3 China Taurine and Derivatives Price by Type (2021-2032)
  5. 11.2 China Taurine and Derivatives Market Size by Application
  6. 11.2.1 China Taurine and Derivatives Revenue by Application (2021-2032)
  7. 11.2.2 China Taurine and Derivatives Sales by Application (2021-2032)
  8. 11.2.3 China Taurine and Derivatives Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Taurine and Derivatives Market Size by Type
  2. 12.1.1 Asia Taurine and Derivatives Revenue by Type (2021-2032)
  3. 12.1.2 Asia Taurine and Derivatives Sales by Type (2021-2032)
  4. 12.1.3 Asia Taurine and Derivatives Price by Type (2021-2032)
  5. 12.2 Asia Taurine and Derivatives Market Size by Application
  6. 12.2.1 Asia Taurine and Derivatives Revenue by Application (2021-2032)
  7. 12.2.2 Asia Taurine and Derivatives Sales by Application (2021-2032)
  8. 12.2.3 Asia Taurine and Derivatives Price by Application (2021-2032)
  9. 12.3 Asia Taurine and Derivatives Market Size by Country
  10. 12.3.1 Asia Taurine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Taurine and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Taurine and Derivatives Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Taurine and Derivatives Market Size by Type
  2. 13.1.1 SAMEA Taurine and Derivatives Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Taurine and Derivatives Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Taurine and Derivatives Price by Type (2021-2032)
  5. 13.2 SAMEA Taurine and Derivatives Market Size by Application
  6. 13.2.1 SAMEA Taurine and Derivatives Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Taurine and Derivatives Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Taurine and Derivatives Price by Application (2021-2032)
  9. 13.3 SAMEA Taurine and Derivatives Market Size by Country
  10. 13.3.1 SAMEA Taurine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Taurine and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Taurine and Derivatives Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Taurine and Derivatives Value Chain Analysis
  2. 14.1.1 Taurine and Derivatives Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Taurine and Derivatives Production Mode & Process
  6. 14.2 Taurine and Derivatives Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Taurine and Derivatives Distributors
  9. 14.2.3 Taurine and Derivatives Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst